35 U.S.C. § 271(e)(1)

35 U.S.C. § 271(e)(1)

Definition

Part of the Drug Price Competition and Patent Term Restoration Act of 1984 (Hatch-Waxman Amendments) that recognizes a research infringement exception for drug and medical device innovators solely for the purposes of submitting information to the Food and Drug Administration.

Get full access FREE

With a 7-Day free trial membership
Here's why 743,000 law students have relied on our key terms:
  • A complete online legal dictionary of law terms and legal definitions
  • Over 7,900 key terms written in plain English to help you not only understand the law but master it
  • The premier online law dictionary built specifically for law students
  • Easy access in class or on the go, accessible both online and through the Quimbee mobile app
  • Reliable - written by legal professors and practitioners
  • Get instant access to all related rules of law to any specific key term with a Quimbee Study Aid plan

Get full access FREE

With a 7-Day free trial membership